Spectral AI Inc - Class A risk profile
83 Acute at or past the historical limit
Measured 21 October 2026 from MDAI's filed statements. Recomputed nightly.
83 (Acute), driven by Concentration at 95, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 79 | Stretched | Volatile | One-year price volatility — 64.6% |
| Operating pressure | 80 | Acute | Worsening | Costs outgrowing revenue — +11.7 percentage points |
| Cash conversion | Reads operating_cashflow, capital_expenditure, free_cashflow, net_income and revenue. No reading is stored for this company. | |||
| Leverage and coverage | 51 | Elevated | Worsening | Interest cover — -5.12x |
| Competitive position | 88 | Acute | Worsening | Operating-margin gap against peers — -22.9 percentage points |
| Concentration | 95 | Acute | Stable | Customer concentration — 8,100 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 33Johnson & Johnson 39Abbvie Inc 57Unitedhealth Group Inc 43Roche Holding AG 35Merck & Co Inc 35Novartis AG 29Novartis AG 31Astrazeneca plc 33Thermo Fisher Scientific Inc 44AMGEN Inc 47Gilead Sciences Inc 51
Financials, valuation and price history for Spectral AI Inc - Class A